🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT05953766
Recruiting Phase 2

Presacral Nerve Block Versus Sham Block on Post-operative Pain for Total Laparoscopic Hysterectomy

NCT05953766 · tracked via the Priya Life Science Canada tracker
Phase
Phase 2
Started
2025-09-24
Last updated
2026-04-06

Condition(s) studied

Post-operative Pain

Investigational drug(s) / intervention(s)

Ropivacaine injection →Normal saline injection

Ropivacaine injection: Presacral nerve block using 20mL of local ropivacaine 5.0mg/ml

Normal saline injection: Sham block using 20 mL of normal saline (0.9% sodium chloride)

Study summary

The study is a single-center parallel group randomized controlled trial comparing the administration of a presacral nerve block using 20mL of local ropivacaine 5.0mg/ml versus 20mL of normal saline (sham block) on post-operative pain following total laparoscopic hysterectomy.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * 18 years of age or older * Undergoing total laparoscopic hysterectomy Exclusion Criteria: * Previous presacral neurectomy * Concurrent surgical procedure other than salpingectomy and/or oophorectomy * Gynecological cancer beyond stage 1 disease * BMI \> 50 * Chronic opioid consumption * Fibromyalgia * Language barrier * Inability to communicate and provide consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Mount Sinai Hospital Toronto Ontario Recruiting

More Mount Sinai Hospital, Canada trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05953766 on ClinicalTrials.gov ↗ ← All trials in Canada